Nimodipine

Nimodipine is a potent calcium channel blocker used in the pharmaceutical industry to manage cerebral vasospasm and improve neurological outcomes after subarachnoid hemorrhage.

SKU: 27025-41-8 Category: Tag:
Description
Nimodipine is, furthermore, a highly specialized dihydropyridine calcium channel blocker supplied by Zyntex for the global pharmaceutical and neurosurgical sectors. This high-purity active pharmaceutical ingredient is globally recognized for its unique ability to cross the blood-brain barrier effectively. In addition, it serves as a fundamental component in the development of modern treatments for cerebral vasospasm following subarachnoid hemorrhage. Therefore, it is extensively utilized as a primary material for manufacturing high-potency oral capsules and intravenous solutions aimed at preventing neurological deficits.

Comprehensive Product Overview

In the production of advanced neurovascular medications, maintaining precise molecular stability and high lipid solubility is a vital technical requirement. Nimodipine is specifically selected because it exhibits a high affinity for cerebral blood vessels, effectively preventing the constriction of arteries in the brain. For instance, our refined grade is processed to ensure strict compliance with international pharmacopeia standards, which is essential for ensuring consistent therapeutic performance in critical care environments. Consequently, it allows for the creation of targeted formulations that protect neural tissue by maintaining adequate blood flow. As a result, Zyntex ensures that our pharmaceutical portfolio supports the global mission of improving neurosurgical recovery through expert chemistry.

Moreover, the high-purity compound provided by Zyntex is a fundamental component in the global “vascular protection” market. This application allows for the treatment of patients during the critical window following a brain injury, undoubtedly meeting the rising clinical demand for reliable neuroprotective therapies. At the same time, its role in the pharmaceutical industry is highly valued for its high selectivity for cerebral arteries compared to peripheral vessels. In short, our product serves as a dependable “specialty” solution for companies focusing on both generic drug manufacturing and innovative neurological intensive care.

Recently, industrial attention has shifted toward using Nimodipine in the development of sustained-release implants for localized brain drug delivery. Because of this, Zyntex provides consistent particle size distribution to ensure optimal bioavailability and formulation stability in various delivery systems. Ultimately, by choosing Zyntex as your supplier, you secure a reliable supply chain that prioritizes regulatory excellence and global logistics expertise. To conclude, our commitment to high-purity active ingredients ensures that your manufacturing processes—whether in liquid infusions or solid oral forms—achieve the highest possible standards of quality.

Key Industrial Applications

This versatile pharmaceutical agent is specifically vital in the following sectors:

🧠 Neurosurgery

Anti-vasospastic; thus providing a critical tool for preventing ischemic damage after brain hemorrhage.

💊 API Supply

Active ingredient; consequently assisting in the production of specialized neurological tablets and infusions.

Technical Specifications

ParameterStandard Value
Product NameNimodipine
Purity GradePharmaceutical Grade (API)
Physical StateLight Yellow Crystalline Powder
CAS Number66085-59-4

🔬 Scientific Data: For detailed pharmacokinetics and neuroprotective profiles of Nimodipine, please visit: PubChem: Nimodipine Technical Details (External Link)